<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Second Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Second Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications</h1>
    <p class="timestamp">Published: 2023-10-10 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>On March 1, 2023 the Drug Enforcement Administration (DEA), in concert with the Department of Health and Human Services (HHS), promulgated two notices of proposed rulemakings (NPRMs) soliciting comments on proposals to allow for prescribing of controlled medications pursuant to the practice of telemedicine in instances where the prescribing practitioner has never conducted an in-person medical evaluation of the patient. On May 10, 2023, following initial review of the comments received, DEA, joi...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Rule</p>
    <p><strong>Agency:</strong> Justice Department, Drug Enforcement Administration, Health and Human Services Department</p>
    <p><strong>Document Number:</strong> 2023-22406</p>
    <p><strong>Publication Date:</strong> 2023-10-10</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/10/10/2023-22406/second-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled">https://www.federalregister.gov/documents/2023/10/10/2023-22406/second-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-22406</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
